Effects of total coronary artery occlusion on vascular endothelial growth factor and transforming growth factor β

Kaohsiung Journal of Medical Sciences

Volumn 21, Issue 10, 2005, Pages 460-465

  Lin, Tsung Hsien ^a   Yen, Hsueh Wei ^a   Su, Ho Ming ^a   Chien, Wan Ting ^a   Lu, Ye Hsu ^a   Voon, Wen Chol ^a   Lai, Wen Ter ^a   Sheu, Sheng Hsiung ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Coronary artery disease; Total occlusion; Transforming growth factor; Vascular endothelial growth factor

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY SINUS; FEMALE; HEART CATHETERIZATION; HEART RIGHT ATRIUM; HUMAN; MALE; PROTEIN DETERMINATION; PROTEIN FUNCTION;

EID: 27844453198     PISSN: 02575655     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1607-551x(09)70151-2     Document Type: Article

References (30)

1. Pepper MS. Manipulating angiogenesis. From basic science to the bedside. Arterioscler Thromb Vasc Biol 1997;17:605-19.
2. Henry TD. Therapeutic angiogenesis. BMJ 1999;318:1536-9.
3. Henry TD, Annex BH, McKendall GR, et al. The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation 2003;107:1359-65.
4. 1: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 1997;8:21-43.
5. Zheng W, Seftor EA, Meininger CJ, et al. Mechanisms of coronary angiogenesis in response to stretch, role of VEGF and TGF-beta. Am J Physiol Heart Circ Physiol 2001;280: H909-17.
6. Risau W. Mechanism of angiogenesis. Nature 1997;386:671-4.
7. Lin TH, Yen HW, Voon WC, et al. Vascular endothelial growth factor in coronary sinus: evidence for its association with coronary collaterals. Scand Cardiovasc J 2005. (in press)
8. Cohen M, Rentrop KP. Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: a prospective study. Circulation 1986;74:469-76.
9. Kawamoto A, Kawata H, Akai Y, et al. Serum levels of VEGF and basic FGF in the subacute phase of myocardial infarction. Int J Cardiol 1998;67:47-54.
10. Piek JJ, Koolen JJ, Hoedemaker G, et al. Severity of single-vessel coronary arterial stenosis and duration of angina as determinants of recruitable collateral vessels during balloon angioplasty occlusion. Am J Cardiol 1991;67:13-7.
11. Engler DA. Use of vascular endothelial growth factor for therapeutic angiogenesis. Circulation 1996;94:1496-8.
12. Banai S, Jaklitsch MT, Shou M, et al. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 1994;89:2183-9.
13. Losordo DW, Vale PR, Symes JF, et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF 165 as sole therapy for myocardial ischaemia. Circulation 1998;98:2800-4.
14. Schultz A, Lavie L, Hochberg I, et al. Interindividual heterogeneity in the hypoxic regulation of VEGF. Circulation 1999;100:547-52.
15. El-Gendi H, Violaris AG, Foale R, et al. Endogenous, local, vascular endothelial growth factor production in patients with chronic total coronary artery occlusions: further evidence for its role in angiogenesis. Heart 2002;87:158-9.
16. Soeki T, Tamura Y, Shinohara H, et al. Serial changes in serum VEGF and HGF in patients with acute myocardial infarction. Cardiology 2000;93:168-74.
17. Hojo Y, Ikeda U, Zhu Y, et al. Expression of vascular endothelial growth factor in patients with acute myocardial infarction. J Am Coll Cardiol 2000;35:968-73.
18. Tamura K, Nakajima H, Rakue H, et al. Elevated circulating levels of basic fibroblast growth factor and vascular endothelial growth factor in patients with acute myocardial infarction. Jpn Circ J 1999;63:357-61.
19. Seko Y, Imai Y, Suzuki S, et al. Serum levels of vascular endothelial growth factor in patients with acute myocardial infarction undergoing reperfusion therapy. Clin Sci 1997;92: 453-4.
20. Ogawa H, Suefuji H, Soejima H, et al. Increased blood vascular endothelial growth factor levels in patients with acute myocardial infarction. Cardiology 2000;93:93-9.
21. Kranz A, Rau C, Kochs M, Waltenberger J. Elevation of vascular endothelial growth factor-A serum levels following acute myocardial infarction. Evidence for its origin and functional significance. J Mol Cell Cardiol 2000;32:65-72.
22. Hasegawa Y, Takanashi S, Kanehira Y, et al. Transforming growth factor-betal level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma. Cancer 2001;91:964-71.
23. Griffioen A, Molema G. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharm Rev 2000;52:237-68.
24. van Royen N, Hoefer I, Buschmann I, et al. Exogenous application of transforming growth factor beta 1 stimulates arteriogenesis in the peripheral circulation. FASEB J 2002;16: 432-4.
25. Werner GS, Jandt E, Krack A, et al. Growth factors in the collateral circulation of chronic total coronary occlusions: relation to duration of occlusion and collateral function. Circulation 2004;110:1940-5.
26. Symes JF, Losordo DW, Vale PR, et al. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. Ann Thorac Surg 1999;68:830-6.
27. Rosengart TK, Lee LY, Patel SR, et al. Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 1999;100:468-74.
28. Vale PR, Symes JF, Esakof DD, et al. Direct myocardial gene transfer of VEGF165 in patients with end-stage coronary artery disease: 12-month results of a phase I/II clinical trial. J Am Coll Cardiol 2001;37(Suppl A):285A. (abstract)
29. Henry TD, Rocha-Singh K, Isner JM, et al. Results of intracoronary recombinant human vascular endothelial growth factor (rhVEGF) administration trial. J Am Coll Cardiol 1998;31(Suppl A):65A. (abstract)
30. Hendel RC, Henry TD, Rocha-Singh K, et al. Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: evidence for a dose-dependent effect. Circulation 2000;101:118-21.